The man who created a drug President Trump is taking to help recover from COVID-19 has previously mentored a virologist known as the Wuhan “batwoman”.
Dr Ralph Baric, who led the team that developed the pharmaceutical remdesivir, also worked on gain-of-function research in the United States before the project was canceled by the US government.
In 2014, the White House Office for Science and Technology Policy asked researchers working on “ gain-of-function ” experiments on influenza, severe acute respiratory syndrome (SARS), and middle respiratory syndrome Orient (MERS) to stop their work until a risk assessment. has been completed.
NPR wrote: “The Obama administration was concerned about any research that might make viruses more dangerous, so they wanted to stop and look at the studies to see if they could make these germs capable of causing more disease or easily spreading around the world. ‘air.
Baric and his team at UNC Chapel Hill received the following letter in 2014 explaining that because their grant is currently funded, “this break is voluntary.”
After receiving the notification, Baric said, “The NIH asked me to stop these experiments and therefore we stopped these experiments.”
“I don’t think it’s wise or appropriate for us to create significant risks that don’t already exist,” says David Relman, a Stanford University microbiologist and reviewer of risky gain-of-function research.
In a 2014 NPR article on “at risk” laboratories, the left-wing outlet asked: “What if this superfluous made in the laboratory escaped?”
A Chinese doctor named Shi Zhengli, known as the “batwoman,” was a senior researcher alongside Baric at the UNC Chapel Hill lab.
In 2015, shortly after their research was postponed, Zhengli and Baric published an article for Nature medicine titled: “A cluster of circulating SARS-like bat coronaviruses shows potential for human emergence.”
In the article, virologists explain “the potential for the emergence (i.e. the potential to infect humans) of circulating bat CoVs, we constructed a chimeric virus encoding a new protein. zoonotic CoV peak – from the RsSHC014-CoV sequence isolated from Chinese horseshoe bats. “
After UN research on Chapel Hill ended, Dr Shi Zhengli became a senior researcher at the Wuhan Institute of Virology of the Chinese Academy of Sciences and director of the Center for Emerging Infectious Diseases.
The Wuhan Institute of Virology has been the focus of interest for many leading scientists and politicians who claim the lab was likely the source of an artificial virus leak.
For example, a 26-page article edited by Chinese virologist Li-Meng Yan claims that SARS-CoV-2 and its closest ancestor RaTG13 were both conceived in a lab.
Dr Yan previously worked in the WHO Reference Laboratory, the world’s largest coronavirus lab, before fleeing to America to try to spread the word about what she says is a virus. artificial released “intentionally” by the Chinese government.
While investigating the origin of the COVID-19 virus during the initial outbreak in Wuhan, Dr Yan found evidence pointing to an intentional release of the Wuhan Institute of Virology from Zhengli and a cover-up by China and the WHO.
After Dr Zhengli left for Wuhan, Dr Baric started working on coronavirus treatments.
According to a North Carolina newspaper, “one of his [Baric] Favorite books were “The Biological Time Bomb,” which predicted things like monoclonal antibodies and recombinant DNA in the 1960s. These ideas of treating infections with antibodies cloned from a human who had a viral infection , then combining genetic material from different sources to create DNA molecules in a lab, stuck with him.
Essentially, Baric has been obsessed with altering human DNA for decades.
A treatment that Baric is involved with, known as remdesivir, was started six years ago.
When COVID-19 started to spread, Baric, who is one of the world’s leading coronavirus experts and mentored the woman accused of allowing the virus to escape from the Wuhan lab, conveniently had a possible treatment.
The $ 6.5 billion NIH Fauci has also given Gilead research into the drug over the years.
A spokesperson said Gilead received about $ 1 billion in NIH funding in 2020 alone.
Center for Integration of Science director Fred Ledley said: “Although it appears that remdesivir has been approved in record time, this drug would not be available today if the NIH and others did not. had not invested billions of dollars over the past decades in basic research on different functioning viruses and nucleoside chemistry. “
An analyst has calculated that the drug could generate $ 2.3 billion in revenue for Gilead this year.
After President Trump announced that he had received a positive COVID-19 test on Friday, he was sent to Walter Reed Hospital that evening.
The president’s treatment at the military center includes a synthetic antibody treatment called Regeneron in combination with remdesivir.
These drugs have serious side effects and are intended for people with severe COVID-19 suffering, unlike POTUS, which had mild symptoms.
Alex Jones revealed the dangerous situation President Trump finds himself in in a special report released on Saturday.
On Saturday, Jon Rappoport explained how the combination of these experimental drugs could be extremely dangerous for President Trump.
Is Dr Baric using his knowledge of the coronavirus to make a fortune selling treatments or trying to help save people from a virus he probably knows to have been created by humans?
#Remdesivir #Creator #mentored #virologist #Wuhan #laboratory #Dateway